Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Viking Line Abp: Financial Statement Release 2023

Viking Line Abp               FINANCIAL STATEMENT RELEASE           16.02.2024, 9.00 AM Viking Line posts historically strong earnings   JANUARY-DECEMBER 2023  (compared to January–December 2022)  · Sales amounted to EUR 491.4 M (EUR 494.7 M). · Other operating revenue was EUR 9.1 M (EUR 24.1 M). · Operating income totalled EUR 55.0 M (EUR 38.3 M). · Net financial items were EUR -9.6 M (EUR -10.3 M). · Income before taxes totalled EUR 45.4 M (EUR 28.0 M). · Income after taxes totalled EUR 36.3 M (EUR 22.7 M). · The Board of Directors proposes a dividend of

Polymer Factory Sweden AB (publ) year-end report, Q4 2023

The period in summary Fourth quarter, October-December 2023 · SpheriCal® ESI was launched as commercially available · Representatives of the Company participated in the second in-person consortium meeting for the Nano-SHIELD project Full year, January-December 2023 · The Board of Directors resolved on a share issue, with subsequent approval by the EGM · The Company raised approx. SEK 6,1 million* through a rights issue of shares · The first instalment of the EDF grant was paid, amounting to approx. SEK 1,8 million** · The Company exhibited and presented at the

New EVP Finance and CFO at Orkla ASA

Arve Regland has been appointed new EVP Finance and CFO at Orkla ASA and will take up the position on 1 June 2024.Arve Regland comes from the investment company Melesio. From 2019 to 2023, he served as CFO at Fredensborg and its subsidiary Heimstaden. From 2014 to 2019, he was employed at Entra, first as CFO and for the last four years as CEO. Mr Regland has also worked at ABG Sundal Collier and Arthur Andersen/Ernst & Young. He has an M.Sc. Business (siviløkonom) from BI Norwegian Business School and an MBA (Master of Professional Accountancy) from the Norwegian School of Economics (NHH).

Year-End Report 1 jan–31 dec 2023

Strong cash flow and increased profitabilityFourth quarter highlights · Revenue decreased by -6.8 per cent to MSEK 2,538 (2,723). Organic growth was -7.5 per cent. · Gross margin increased to 43.4 per cent (41.4). · Adjusted EBITA increased by 3 per cent to MSEK 308 (298), corresponding to an adjusted EBITA margin of 12.1 per cent (10.9). · Operating profit increased to MSEK 278 (268) and the operating margin was 11.0 per cent (9.8). Operating profit was charged with items affecting comparability of MSEK -16 (-15). · Profit amounted to MSEK 192 (194). · Earnings per

Notice convening the Annual General Meeting of AB Electrolux

The shareholders of AB Electrolux, reg. no. 556009-4178 (the “Company”), are hereby given notice of the Annual General Meeting to be held on Wednesday, March 27, 2024, at 4.00 p.m. (CET) at Nalen, Regeringsgatan 74 in Stockholm, Sweden. Admission and registration will commence at 3.15 p.m. (CET).The Board of Directors has decided that the shareholders shall have the possibility to exercise their voting rights by postal voting before the Annual General Meeting, as instructed below. The Annual General Meeting will be webcasted live via Electrolux Group’s website, www.electroluxgroup.com/

United Bankers Plc’s Financial Statements Bulletin 2023: Record profit supported by new strategic funds

United Bankers Plc 16 February 2024 at 9:00 EET United Bankers Plc’s Financial Statements Bulletin 2023: Record profit supported by new strategic funds This stock exchange release is a summary of the United Bankers’ Financial Statements Bulletin 1 January – 31 December 2023. The complete Financial Statements Bulletin with tables is attached to this release and is also available on the company’s website at www.unitedbankers.fi. The figures in this release are unaudited. January-December 2023 in brief · The Group’s revenue (income from operations) in the financial period

Stille AB: Year-End Report 2023

Stille AB (publ) today presents the report for the fourth quarter and full fiscal year 2023. ”Strong finish to the year with solid sales growth, enhanced profitability and the strategic acquisition of Fehling Instruments”, summarizes President and CEO Torbjörn Sköld in the year-end report.Revenue increased in the fourth quarter by 25.0 percent to 77.3 MSEK (61.8) with strong growth from both business units. “I am pleased to note that our growth momentum remains strong in the fourth quarter, and we continue to deliver on our growth strategy. 2023 marked a significant milestone for Stille.”,

ContextVision publishes Webcast for Q4 2023

Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision's highlights from Q4 2023 along the financials for the quarter and full year.  The Webcast is available on ContextVision's website following the link below: https://www.contextvision.com/investors/webcast/ For more details, contact ContextVision's CFO, Richard Hallström at richard.hallstrom@contextvision.com or visit our official website at www.contextvision.com. About ContextVisionContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the

Changes to Intrum’s Group Management Team

Emil Folkesson has been appointed interim CFO of Intrum. Anders Blomqvist, who took on the interim CFO role in December, remains as Senior Consultant reporting directly to CEO Andrés Rubio. The changes take effect from 16 February. In addition, new regional directors have been named for North and Middle Europe.“Since Anders Blomqvist joined Intrum as interim CFO mid-December, the focus has been to close and announce the fourth quarter of 2023 and to finalise the asset sale to Cerberus which we announced 23 January”, says Andrés Rubio, President & CEO of Intrum. “As we now have these two

SaltX Technology Holding AB Year-end Report 2023

SaltX Technology is a Swedish Greentech company that develops and markets sustainable technology that benefits customers, the climate, and society. Today, the company issued its Year-end Report for 2023.“We are at the beginning of industrialization and commercialization, where we now level up to meet the growing demand for our electrification technology. We aim to become an industrial supplier significantly reducing global carbon dioxide emissions." - Carl-Johan Linér, CEO SaltX  Presentation of the Year-end Report The report is presented in a video interview where SaltX CEO Carl-

Year-end report 2023

Strong company and positive outlookJohn Mattson’s net operating income per share increased 10% during 2023, while EBIT increased 14%. This despite a year of persistent high inflation, non-recurring costs of SEK 3 million and a smaller property portfolio as a result of divestments in 2022 and 2023. In comparable holdings, net operating income increased 20% and EBIT increased 27%.The surplus ratio amounted to 72%, which is a record high for the company. This was primarily the result of the efficiency and cost-savings programme launched in autumn 2022 and completed in 2023. As a result of

RANPLAN GROUP AB – Interim Report July - Dec 2023

2024-02-16 08:00 CET The period in summary Second half of 2023 (second half of 2022)         Total income amounted to SEK 15.4 million (15.1 million)1       Net sales amounted to SEK 9.4 million (9.7 million)       Operating income amounted to SEK -9.6 million (-12.6 million)       Net income amounted to SEK -11.3 million (-13.0 million)       Earnings per share amounted to SEK -0.36 (-0.43)       Cash at the end of the period amounted to SEK 1.5 million (5.1 million)   Full year of 2023 (Full year of 2022)         Total income amounted to SEK

Oneflow year-end report 2023: Breaking old records is becoming a habit

Press release16 February 2024 Oneflow publishes its year-end report for January–December 2023: October–December 2023 (compared to the same period last year) · Net sales increased 39.5% to MSEK 28.4 (20.4). Share of Net sales outside Sweden increased to 33% (28) with paying users in 40 countries. · EBIT was MSEK -26.5 (-24.4), with an EBIT margin of -93% (-120). · Net income for the period amounted to -26.3 (-24.0). · Basic earnings per share amounted to SEK -1.05 (-0.95) and diluted to SEK -1.05 (-0.95). · Total ARR YoY increased 42.7% to MSEK 129.3 (90.6). Net New

Remedy Entertainment Plc: Remedy announces sales information for Alan Wake 2

Remedy Entertainment Plc Stock Exchange Release         February 16, 2024 at 9:00 a.m. EET   Remedy announces sales information for Alan Wake 2 Alan Wake 2 was released in October 2023 to worldwide critical acclaim, earning a Metacritic score of 89 at launch. Today, Remedy Entertainment Plc (“Remedy”) announces that Alan Wake 2 has sold 1 million units by the end of December 2023, and 1.3 million units as of the beginning of February 2024. Alan Wake 2 is Remedy’s fastest selling game so far. By comparison, Alan Wake 2 sold over 50% more copies and over three times more digital

Transaction in Own Shares

    16 February 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |15/02/2024|+----------------------------------------------------------

Corem divests two properties in Gothenburg and Malmö for SEK 101 million

In two separate deals, Corem has signed agreements for the sale of two properties in Gothenburg and Malmö at a total underlying property value of SEK 101 milllion, which is in line with book value.   In Gothenburg, the property Backa 25:1 is sold, and in Malmö, the property Smörbollen 12 is sold.   The properties have a total lettable area of approximately 8,000 square meters and a total rental value of approximately SEK 8.2 million.   Transfer of possession of both properties is planned for 15 March 2024.   Corem Property Group AB (publ)FOR FURTHER INFORMATION,

New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL

STOCKHOLM, SWEDEN, - February 16, 2024 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced today the publication of the first direct comparison between electrical impedance spectroscopy (EIS) using Nevisense and trans-epidermal water loss (TEWL). The study demonstrates Nevisense as a more robust technique to assess skin barrier function than the commonly accepted TEWL measurement technique.Skin barrier function has been implicated as a driving factor in many dermatological disorders, including Atopic

The Board of AcadeMedia has set the terms for the voluntary redemption program

On 30 November 2023, AcadeMedia’s Annual General Meeting resolved, in accordance with the proposal from the Board, on a voluntary redemption program, comprising a reduction of the share capital for repayment to the shareholders and a bonus issue without issuance of new shares. The Board of AcadeMedia has now set the terms of the voluntary redemption program, based on the authorization granted by the Annual General Meeting. Not more than 4,223,502 ordinary shares may be redeemed and thus, the share capital may be reduced by not more than SEK 4,223,502. The share capital reduction will be

Implantica publishes Year-end Report, January – December 2023 (Q4)

RefluxStop™ – Gaining speed, breaking boundaries and going globalSignificant events in the fourth quarter of 2023 · Selected U.S. surgeons begin the standardized RefluxStop™ surgery training program · in preparation for Cadaver Usability study during Q1 2024 · from over 10 key centers in U.S. · results to be used in our PMA application to FDA · Successful 2nd Annual RefluxStop™ Users Meeting · > 50 participants attended · surgeons and GIs from U.S., Canada, U.K. and across Europe · RefluxStop™ cost-effectiveness research received top recognition at

Enzymatica’s Board of Directors decides on a new rights issue of SEK 27.4 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR INVOLVE REQUIREMENTS FOR MEASURES OTHER THAN WHAT FOLLOWS BY SWEDISH LAW. The Board of Directors of Enzymatica AB (publ) (“Enzymatica” or the “Company”) has decided to carry out a rights issue amounting to SEK 27.4 million, with preferential rights for existing shareholders, by exercising the

Metso’s Financial Statements Review January-December 31, 2023

Metso Corporation’s stock exchange release on February 16, 2024, at 09:00 a.m. EETMetso revised its segment reporting as of September 30, 2023, by transitioning from three segments to two: Aggregates and Minerals. The Smelting business, previously reported under the Metals segment, was moved to the Minerals segment, and the Metals & Chemical Processing and Ferrous & Heat Transfer businesses from the Metals segment were transferred to discontinued operations. All income statement, order intake and order backlog figures presented in this report pertain to continuing operations, and the

Exel Composites’ Financial Statements Release Q1–Q4 2023: 2023 revenue EUR 96.8 million and adjusted operating profit EUR -2.4 million

EXEL COMPOSITES PLC     FINANCIAL STATEMENT RELEASE       16.2.2024 at 09:00 EETQ4 2023 in brief · Order intake decreased by 8.0% to EUR 23.6 million (Q4 2022: 25.6) · Revenue decreased by 28.8% to EUR 22.1 million (31.0) · Adjusted operating profit decreased to EUR -1.3 million (0.9) and adjusted operating profit margin to -5.9% (3.0%) · Operating profit decreased to EUR -3.7 million (-1.7) and operating profit margin to -16.7% (-5.5%) · Earnings per share was EUR -0.47 (-0.32) Q1-Q4 2023 in brief · Order intake decreased by 21.3% to EUR 98.1 million (Q1-Q4 2022:

Cell Impact Q4 2023: Expected weak quarter but financing secured

The fourth quarter turned out to be very weak as previously announced, but Cell Impact’s sales will gradually increase in the coming quarters, albeit from a low level. During the quarter, financing for the company's ongoing development was secured, the cost reduction program announced in July 2023 was concluded and an additional cost reduction program was initiated. Our full focus is now directed toward developing both customer projects and taking further steps in Phase II, our productivity and profitability program.The company’s sales will gradually increase in the coming quarters, not

There are no items matching the current filter
There are no more items matching the current filter
Back to top